Addiction
How Psilocybin Affects Depression, Anxiety, and Substance Use in Real-Life Settings
While clinical trials have shown promise in treating depression, anxiety, and substance use disorders, little is known about how psilocybin
While clinical trials have shown promise in treating depression, anxiety, and substance use disorders, little is known about how psilocybin
Psychedelics may act as catalysts for nervous system regulation and embodied memory processing, bringing suppressed trauma to the surface.
Ayahuasca may serve as a powerful tool for transformation for Middle Eastern and North African (MENA) immigrants and refugees.
Recent research suggests that psilocybin shows promise in treating addiction. Studies have demonstrated its potential efficacy in treating tobacco and
Results from our recent large-scale study with John Hopkins University found significantly decreased depression persisting for months following psilocybin ingestion.
Psilocybin has been used safely for patients with OCD and was associated with acute reductions in core OCD symptoms in
HPPD is a rare clinical condition that results in people experiencing visual and perceptual distortions days, months, or even years
While the research on using psychedelics for the treatment of addiction is still in its early stages, findings are promising.
A recent series of case studies provided promising preliminary evidence for the potential of microdosing in treating chronic pain.
HPPD is a rare clinical condition that results in people experience visual and perceptual distortions days, months, or even years
©2025 Unlimited Sciences. All rights reserved.
We hate pop-ups as much as you do, but if you want to stay up to date about the latest news in the psychedelic space and learn about our ground-breaking psychedelic research, please consider signing up for our newsletter below.